International Patent: POLYOLIGONUCLEOTIDE CAPABLE OF TRIGGERING GENE SILENCING

GENEVA, July 1 -- VISIRNA THERAPEUTICS (SUZHOU) CO., LTD. filed a patent application (CN2025/142651) for “POLYOLIGONUCLEOTIDE CAPABLE OF TRIGGERING GENE SILENCING”. With publication no. WO/2026/124680, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....